ArticleMedical & biological engineering & computing2026
A novel multimodal AI framework for early diagnosis of idiopathic Parkinson's disease.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by motor symptoms, but early diagnosis is challenging due to symptom overlap with other conditions and a lack of definitive biomarkers (clinical assessments). In this study, we propose a novel multimodal artificial intelligence (AI)-based decision support system aimed at the early diagnosis of idiopathic PD. To the best of our knowledge, this is the first framework to enable the synchronous analysis of four distinct modalities: walking, facial expression, voice, and posture, whereas prior studies have typically focused on unimodal or partially multimodal approaches. We also constructed a new dataset by establishing a controlled clinical testing environment equipped with an L-shaped walking track and an integrated audiovisual recording system to capture natural walking, turning, facial, vocal, and postural characteristics. For each modality, specialized AI models were developed and evaluated. For the walking modality, the proposed Bidirectional GRU model achieved the best performance in terms of both [Formula: see text] score (92.74%) and area under the curve (AUC) (97.86%), demonstrating superior gait-based classification performance. Similarly, in the face modality, the ensemble model integrating eXtreme Gradient Boosting (XGBoost), Random Forest (RF), and Categorical Boosting (CatBoost) yielded the highest [Formula: see text] score (92.31%) while also achieving the best AUC (97.96%). For the voice and posture modalities, although the highest [Formula: see text] scores were not obtained, the RF-based models achieved the highest AUC values (99.85% and 97.56%, respectively) within their respective modality comparisons in the literature, reflecting strong class separability and discriminative capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.